Mostrar el registro sencillo del ítem
dc.contributor.author
Diamanti Kandarakis, Evanthia
dc.contributor.author
Spritzer, Poli Mara
dc.contributor.author
Sir Petermann, Teresa
dc.contributor.author
Motta, Alicia Beatriz
dc.date.available
2017-05-31T21:41:27Z
dc.date.issued
2012-07
dc.identifier.citation
Diamanti Kandarakis, Evanthia; Spritzer, Poli Mara; Sir Petermann, Teresa; Motta, Alicia Beatriz; Insulin resistance and polycystic ovary syndrome through life; Bentham Science Publishers; Current Pharmaceutical Design.; 18; 34; 7-2012; 5569-5576
dc.identifier.issn
1381-6128
dc.identifier.uri
http://hdl.handle.net/11336/17237
dc.description.abstract
The heterogeneity of Polycystic Ovary Syndrome (PCOS) emphasizes the need for a consensual review of the data concerning its diagnosis and treatment and for determination of the relationship between the development of PCOS and the ethnic origin, the social status and the lifespan. Insulin resistance is an important characteristic in women with PCOS that aggravates features of PCOS. This review is focused in the diagnosis and treatment of insulin resistance and the risk factors for PCOS during childhood, adolescence and postmenopause. The role of endocrine disruptors and/or their interaction with PCOS have also been analyzed.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Bentham Science Publishers
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
Polycystic Ovary Syndrome
dc.subject
Insulin Resistance
dc.subject
Child
dc.subject
Adolescence
dc.subject
Menopause
dc.subject
Treatments
dc.subject
Diagnosis
dc.subject
Endocrine
dc.subject
Risk Factors
dc.subject
Testosterone
dc.subject.classification
Obstetricia y Ginecología
dc.subject.classification
Medicina Clínica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Insulin resistance and polycystic ovary syndrome through life
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2017-05-31T20:03:49Z
dc.identifier.eissn
1873-4286
dc.journal.volume
18
dc.journal.number
34
dc.journal.pagination
5569-5576
dc.journal.pais
Emiratos Árabes Unidos
dc.journal.ciudad
Sharjah
dc.description.fil
Fil: Diamanti Kandarakis, Evanthia. Universidad Nacional y Kapodistriaca de Atenas; Grecia
dc.description.fil
Fil: Spritzer, Poli Mara. Universidade Federal do Rio Grande do Sul; Brasil
dc.description.fil
Fil: Sir Petermann, Teresa. Universidad de Chile; Chile
dc.description.fil
Fil: Motta, Alicia Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina
dc.journal.title
Current Pharmaceutical Design.
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://www.eurekaselect.com/103435/article
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.2174/138161212803307590
Archivos asociados
Tamaño:
225.5Kb
Formato:
PDF